Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

The meeting covered new findings in children's skin conditions and treatments, including the benefits of super absorbent polymer diapers.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Platelet lysate could be a valuable treatment for many diseases in regenerative medicine.

Skin problems can indicate different diseases inside the body.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Mesenchymal stem cells are effective and safe for treating various diseases in children.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.